Is Boundless Bio, Inc. (BOLD) a Buy, Sell, or Hold?
NASDAQ : BOLD
Boundless Bio, Inc. — Institutional Ownership
$2.89 USD
$0.05 (1.76%)
- Volume
- 940.36K
- Average Volume
- 1.21M
- Market Capitalization
- $64.95M
- P/E Ratio
- -1.01
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $2.92
- Year Low
- $0.96
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.48
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-06-29 | TANG CAPITAL MANAGEMENT, LLC | 2.53M | 11.30% |
| 2026-02-17 | Nextech VI GP S.a. r.l. | - | 0.00% |
| 2026-02-05 | FMR LLC | 2.68M | 12.00% |
| 2025-12-04 | Citadel Advisors LLC | 830.94K | 3.70% |
| 2025-08-14 | RA Capital Management, L.P. | - | 0.00% |
| 2024-10-29 | Steven Gillis | 2.69M | 12.10% |
| 2024-10-29 | Robert Nelsen | 2.69M | 12.10% |
| 2024-10-29 | ARCH Venture Fund IX, L.P. | 2.69M | 12.10% |
| 2024-10-29 | ARCH Venture Partners X Overage, L.P. | 2.69M | 12.10% |
| 2024-10-29 | ARCH Venture Partners IX, LLC | 2.69M | 12.10% |
| 2024-10-29 | Keith Crandell | 2.69M | 12.10% |
| 2024-10-29 | Kristina Burow | 2.7M | 12.10% |
| 2024-10-29 | Clinton Bybee | 2.69M | 12.10% |
| 2024-10-29 | ARCH Venture Fund IX Overage, L.P. | 2.69M | 12.10% |
| 2024-10-29 | ARCH Venture Fund X Overage, L.P. | 2.69M | 12.10% |
| 2024-10-29 | ARCH Venture Partners IX, L.P. | 2.69M | 12.10% |
| 2024-10-29 | ARCH Venture Partners IX Overage, L.P. | 2.69M | 12.10% |
| 2024-10-29 | ARCH Venture Partners X, LLC | 2.69M | 12.10% |
| 2024-04-12 | Peter Kolchinsky | 2.18M | 9.80% |
| 2024-04-12 | Ian Charoub | 1.23M | 5.50% |
| 2024-04-12 | Nextech VI GP S.à. r.l. | 1.23M | 5.50% |
| 2024-04-12 | Nextech VI Oncology SCSp | 1.23M | 5.50% |
| 2024-04-12 | Costas Constantinides | 1.23M | 5.50% |
| 2024-04-12 | Rocco Sgobbo | 1.23M | 5.50% |
| 2024-04-12 | RA Capital Healthcare Fund, L.P. | 1.88M | 8.50% |
| 2024-04-12 | Rajeev Shah | 2.18M | 9.80% |
| 2024-04-12 | RA Capital Management, L.P. | 2.18M | 9.80% |
| 2024-04-10 | Abigail P. Johnson | 3.26M | 14.67% |
| 2024-04-10 | FMR LLC | 3.26M | 14.67% |
| 2024-04-09 | Bayer HealthCare LLC | 1.62M | 7.30% |
| 2024-04-09 | Bayer World Investments B.V. | 1.62M | 7.30% |
| 2024-04-09 | Bayer Aktiengesellschaft | 1.62M | 7.30% |
| 2024-04-09 | Bayer US Holding LP | 1.62M | 7.30% |
BOLD Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.20 | 22.36M | $26.83M | $17.87M | $49.04M | $58M |
| 2024-12-31 | $2.90 | 16.98M | $49.25M | $26.59M | $47.63M | $70.3M |
| 2023-12-31 | $14.25 | 22.24M | $316.91M | $23.71M | $2.2M | $295.4M |
| 2022-12-31 | $14.25 | 22.24M | $316.91M | $10.95M | $5.18M | $311.14M |
| 2021-12-31 | $14.25 | 22.24M | $316.91M | $34.29M | $377K | $283M |
| 2018-12-31 | $14.25 | 44.03M | $627.4M | $144.35M | $7.06M | $490.12M |
| 2017-12-31 | $14.25 | 44.03M | $627.4M | $38.97M | $7.18M | $595.61M |
| 2016-12-31 | $14.25 | 44.03M | $627.4M | $36.36M | $2.75M | $593.79M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2.50 | 22.45M | $56.12M | $20.21M | -$ | $35.91M |
| 2026-03-31 | $1.10 | 22.41M | $24.65M | $17.48M | $48.29M | $55.45M |
| 2025-12-31 | $1.20 | 22.36M | $26.83M | $17.87M | $49.04M | $58M |
| 2025-09-30 | $1.23 | 22.39M | $27.53M | $14.98M | $49.76M | $62.31M |
| 2025-06-30 | $1.01 | 22.36M | $22.58M | $14.7M | $49.51M | $57.39M |
| 2025-03-31 | $1.51 | 22.3M | $33.67M | $15.12M | $48.57M | $67.13M |
| 2024-12-31 | $2.90 | 16.98M | $49.25M | $26.59M | $47.63M | $70.3M |
| 2024-09-30 | $3.47 | 22.25M | $77.22M | $40.21M | $121K | $37.13M |
| 2024-06-30 | $4.19 | 22.02M | $92.28M | $31.36M | $837K | $61.75M |
| 2024-03-31 | $13.54 | 22.24M | $301.12M | $25.14M | $1.52M | $277.5M |
| 2023-12-31 | $14.25 | 22.24M | $316.91M | $23.71M | $2.2M | $295.4M |
| 2023-09-30 | $14.25 | 22.24M | $316.91M | $20.96M | $4.38M | $300.32M |